Literature DB >> 14735254

Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure.

J M Costello1, C L Backer, P A Checchia, C Mavroudis, R G Seipelt, D M Goodman.   

Abstract

This study examined changes in the natriuretic hormone system in five infants with congestive heart failure (CHF) due to intracardiac left-to-right shunting who were exposed to cardiopulmonary bypass (CPB) during surgical repair. Plasma concentrations of three hormones [atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and dendroaspis natriuretic peptide (DNP)] and their secondary messenger, guanosine 3',5'-monophosphate (cGMP), were measured, and the biological activity of the system was quantified. At baseline, BNP and DNP concentrations were normal in our patients, a finding that is strikingly different from that of adult CHF patients, whereas ANP concentrations were elevated. Following CPB, ANP concentrations decreased (median, 175 vs 44 pg/ml; p = 0.043) and BNP concentrations increased (median, 25 vs 66 pg/ ml; p = 0.043), whereas DNP concentrations did not change. Following modified ultrafiltration, BNP concentrations increased (p = 0.043), but other natriuretic peptide concentrations did not change. The calculated biological activity of the natriuretic hormone system decreased following CPB [molar ratio, cGMP / (ANP + BNP + DNP); median, 213 vs 127; p = 0.043)]. Additional studies are needed to expand on these findings and identify patients with other types of congenital heart disease who have perioperative disturbances in the natriuretic hormone system and thus might benefit from pharmacologic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14735254     DOI: 10.1007/s00246-003-0512-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  36 in total

1.  Biological activity of endogenous atrial natriuretic peptide during cardiopulmonary bypass.

Authors:  N Hayashida; S Chihara; H Kashikie; E Tayama; S Yokose; K Akasu; S Aoyagi
Journal:  Artif Organs       Date:  2000-10       Impact factor: 3.094

2.  Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations.

Authors:  M C Seghaye; J Duchateau; J Bruniaux; S Demontoux; H Détruit; C Bosson; G Lecronier; E Mokhfi; A Serraf; C Planché
Journal:  Crit Care Med       Date:  1997-06       Impact factor: 7.598

3.  Atrial natriuretic factor-induced egression of cyclic guanosine 3':5'-monophosphate in cultured vascular smooth muscle and endothelial cells.

Authors:  P Hamet; S C Pang; J Tremblay
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

4.  Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.

Authors:  C J Charles; E A Espiner; M G Nicholls; A M Richards; T G Yandle; A Protter; T Kosoglou
Journal:  Am J Physiol       Date:  1996-08

5.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Authors:  K Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

6.  Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure.

Authors:  S D Katz; K Balidemaj; S Homma; H Wu; J Wang; S Maybaum
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

7.  Hemodynamic and hormonal responses to hypothermic and normothermic cardiopulmonary bypass.

Authors:  J J Lehot; J Villard; H Piriz; D M Philbin; P Y Carry; G Gauquelin; B Claustrat; G Sassolas; J Galliot; S Estanove
Journal:  J Cardiothorac Vasc Anesth       Date:  1992-04       Impact factor: 2.628

8.  Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.

Authors:  R J Cody; G J Haas; P F Binkley; Q Capers; R Kelley
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

9.  Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; E Morita; N Sakaino; M Jougasaki; M Kurose; M Mukoyama; Y Saito; K Nakao; H Imura
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

10.  Influence of hypothermic cardiopulmonary bypass on atrial natriuretic factor levels.

Authors:  E D Kharasch; K T Yeo; M A Kenny; D W Amory
Journal:  Can J Anaesth       Date:  1989-09       Impact factor: 5.063

View more
  4 in total

1.  Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery.

Authors:  T S Mir; C Haun; C Lilje; S Läer; J Weil
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

2.  Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease.

Authors:  J G Berry; B Askovich; R E Shaddy; J A Hawkins; C G Cowley
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

3.  Value of brain natriuretic peptide in the perioperative follow-up of children with valvular disease.

Authors:  Pierre Tissières; Eduardo da Cruz; Walid Habre; Yacine Aggoun; Noury Mensi; Afksendyios Kalangos; Maurice Beghetti
Journal:  Intensive Care Med       Date:  2008-02-19       Impact factor: 17.440

4.  Relationship between increased blood pressure and hematocrit during modified ultrafiltration for pediatric open heart surgery.

Authors:  Shin Takabayashi; Hideto Shimpo; Kazuto Yokoyama; Hideki Iwata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.